A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer
Clinical trial NCT00144053 · COMPLETED
Trial details
- NCT number
- NCT00144053
- Sponsor
- West Japan Thoracic Oncology Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-04-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.